Lv2
110 积分 2026-01-09 加入
Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitors
8小时前
待确认
Cancer immunotherapy in elderly patients: The concept of immune senescence challenged by clinical experience
1个月前
已完结
Immunosenescence in elderly patients with advanced non-small cell lung cancer: Mechanisms and therapeutic implications
1个月前
已完结
NIR-II Imaging-Guided Phototherapy-Induced Senescence Reprograms Immunosuppressive Tumor Microenvironment for Potent Cancer Immunotherapy
1个月前
已完结
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy
1个月前
已完结
Mechanisms and strategies of immunosenescence effects on non-small cell lung cancer (NSCLC) treatment: A comprehensive analysis and future directions
1个月前
已完结
Current status and prospect of immunotherapy for colorectal cancer
2个月前
已完结
[A randomized controlled study of erlotinib versus pemetrexed combined with cisplatin in neoadjuvant therapy of stage ⅢA EGFR-mutant lung adenocarcinoma]
7个月前
已完结
MA04.02 Nautika1: Clinical Outcomes and Pathologic Regression With Neoadjuvant Alectinib in Resectable Stage IB-IIIB ALK + NSCLC
7个月前
已关闭
皖公网安备34019202002308
